Randomized controlled trial of acupuncture for prevention of radiation-induced xerostomia among patients with nasopharyngeal carcinoma

Cancer

Volumn 118, Issue 13, 2012, Pages 3337-3344

  Meng, Zhiqiang ^a   Garcia, M Kay ^b   Hu, Chaosu ^a   Chiang, Joseph ^c   Chambers, Mark ^b   Rosenthal, David I ^b   Peng, Huiting ^a   Zhang, Ying ^a   Zhao, Qi ^b,d   Zhao, Genming ^d   Liu, Luming ^a   Spelman, Amy ^b   Palmer, J Lynn ^b   Wei, Qi ^b   Cohen, Lorenzo ^b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d FUDAN UNIVERSITY   (China)

Author keywords

Acupuncture; Head and neck cancer; Quality of life; Xerostomia

Indexed keywords

ACUPUNCTURE; ADULT; ARTICLE; CANCER RADIOTHERAPY; CHINA; CONTROLLED STUDY; FEMALE; FLOW RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MD ANDERSON SYMPTOM INVENTORY HEAD AND NECK; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SALIVA; SCORING SYSTEM; XEROSTOMIA; XEROSTOMIA QUESTIONNAIRE;

ACUPUNCTURE THERAPY; ADULT; FEMALE; HUMANS; MALE; NASOPHARYNGEAL NEOPLASMS; QUALITY OF LIFE; RADIATION INJURIES; RADIOTHERAPY; XEROSTOMIA; YOUNG ADULT;

EID: 84862567352     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26550     Document Type: Article

References (49)

1. Chambers MS, Rosenthal DI, Weber RS,. Radiation-induced xerostomia. Head Neck. 2007; 29: 58-63. (Pubitemid 46032568)
2. Bertram U,. Xerostomia. Clinical aspects, pathology and pathogenesis. Acta Odontol Scand. 1967; 25 (suppl 49): 41-126.
3. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991; 21: 109-122.
4. Chambers MS, Toth BB, Martin JW, Fleming TJ, Lemon JC,. Oral and dental management of the cancer patient: prevention and treatment of complications. Support Care Cancer. 1995; 3: 168-175.
5. Chambers MS,. Clinical commentary on prophylactic treatment of radiation-induced xerostomia. Arch Otolaryngol Head Neck Surg. 2003; 129: 251-252. (Pubitemid 36222580)
6. Mendenhall WM, Amdur RJ, Morris CG, Kirwan JM, Li JG,. Intensity-modulated radiotherapy for oropharyngeal squamous cell carcinoma. Laryngoscope. 2010; 120: 2218-2222.
7. Mendenhall WM, Amdur RJ, Palta JR,. Intensity-modulated radiotherapy in the standard management of head and neck cancer: promises and pitfalls. J Clin Oncol. 2006; 24: 2618-2623. (Pubitemid 46622082)
8. Pacholke HD, Amdur RJ, Louis DA, Yang H, Mendenhall WM,. The role of intensity modulated radiation therapy for favorable stage tumor of the nasal cavity or ethmoid sinus. Am J Clin Oncol. 2005; 28: 474-478. (Pubitemid 41437386)
9. Pacholke HD, Amdur RJ, Morris CG, et al. Late xerostomia after intensity-modulated radiation therapy versus conventional radiotherapy. Am J Clin Oncol. 2005; 28: 351-358. (Pubitemid 41099539)
10. Eisbruch A, Rhodus N, Rosenthal D, et al. The prevention and treatment of radiotherapy-induced xerostomia. Semin Radiat Oncol. 2003; 13: 302-308. (Pubitemid 36962652)
11. Amosson CM, Teh BS, Van TJ, et al. Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost technique. Int J Radiat Oncol Biol Phys. 2003; 56: 136-144. (Pubitemid 36403685)
12. Eisbruch A, Kim HM, Terrell JE, Marsh LH, Dawson LA, Ship JA,. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001; 50: 695-704. (Pubitemid 32515326)
13. Eisbruch A, Ten Haken RK, Kim HM, Marsh LH, Ship JA,. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys. 1999; 45: 577-587. (Pubitemid 29462636)
14. Pow EH, Kwong DL, McMillan AS, et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys. 2006; 66: 981-991. (Pubitemid 44633504)
15. Chao KS, Majhail N, Huang CJ, et al. Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques. Radiother Oncol. 2001; 61: 275-280. (Pubitemid 33127232)
16. Lee N, Xia P, Quivey JM, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys. 2002; 53: 12-22. (Pubitemid 34465802)
17. Garcia MK, Chiang JS, Cohen L, et al. Acupuncture for radiation-induced xerostomia in patients with cancer: a pilot study. Head Neck. 2009; 31: 1360-1368.
18. Fox PC, Van der Ven PF, Baum BJ, Mandel ID,. Pilocarpine for the treatment of xerostomia associated with salivary gland dysfunction. Oral Surg Oral Med Oral Pathol. 1986; 61: 243-248. (Pubitemid 16137380)
19. Greenspan D, Daniels TE,. Effectiveness of pilocarpine in postradiation xerostomia. Cancer. 1987; 59: 1123-1125. (Pubitemid 17040390)
20. Johnson JT, Ferretti GA, Nethery WJ, et al. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. N Engl J Med. 1993; 329: 390-395. (Pubitemid 23219343)
21. Zimmerman RP, Mark RJ, Tran LM, Juillard GF,. Concomitant pilocarpine during head and neck irradiation is associated with decreased posttreatment xerostomia. Int J Radiat Oncol Biol Phys. 1997; 37: 571-575. (Pubitemid 27175312)
22. Horiot JC, Lipinski F, Schraub S, et al. Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative study. Radiother Oncol. 2000; 55: 233-239. (Pubitemid 30408369)
23. Brizel DM, Wasserman TH, Henke M, et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol. 2000; 18: 3339-3345.
24. Rudat V, Meyer J, Momm F, et al. Protective effect of amifostine on dental health after radiotherapy of the head and neck. Int J Radiat Oncol Biol Phys. 2000; 48: 1339-1343.
25. Wasserman T, Mackowiak JI, Brizel DM, et al. Effect of amifostine on patient assessed clinical benefit in irradiated head and neck cancer. Int J Radiat Oncol Biol Phys. 2000; 48: 1035-1039.
26. Lindegaard JC, Grau C,. Has the outlook improved for amifostine as a clinical radioprotector? Radiother Oncol. 2000; 57: 113-118.
27. Jha N, Seikaly H, Harris J, et al. Phase III randomized study: oral pilocarpine versus submandibular salivary gland transfer protocol for the management of radiation-induced xerostomia. Head Neck. 2009; 31: 234-243.
28. Weiss WW Jr, Brenman HS, Katz P, Bennett JA,. Use of an electronic stimulator for the treatment of dry mouth. J Oral Maxillofac Surg. 1986; 44: 845-850. (Pubitemid 16009066)
29. Steller M, Chou L, Daniels TE,. Electrical stimulation of salivary flow in patients with Sjogren's syndrome. J Dent Res. 1988; 67: 1334-1337.
30. Fontanesi J, Golden EB, Cianci P,. Hyperbaric oxygen therapy can reverse radiation-induced xerostomia. J Hyperbaric Med. 1991; 6: 215-221.
31. Rydholm M, Strang P,. Acupuncture for patients in hospital-based home care suffering from xerostomia. J Palliat Care. 1999; 15: 20-23.
32. Blom M, Lundeberg T,. Long-term follow-up of patients treated with acupuncture for xerostomia and the influence of additional treatment. Oral Dis. 2000; 6: 15-24. (Pubitemid 30090221)
33. Blom M, Dawidson I, Angmar-Mansson B,. The effect of acupuncture on salivary flow rates in patients with xerostomia. Oral Surg Oral Med Oral Pathol. 1992; 73: 293-298.
34. Blom M, Lundeberg T, Dawidson I, Angmar-Mansson B,. Effects on local blood flux of acupuncture stimulation used to treat xerostomia in patients suffering from Sjogren's syndrome. J Oral Rehabil. 1993; 20: 541-548.
35. Blom M, Dawidson I, Fernberg JO, Johnson G, Angmar-Mansson B,. Acupuncture treatment of patients with radiation-induced xerostomia. Eur J Cancer B Oral Oncol. 1996; 32B: 182-190.
36. Dawidson I, Blom M, Lundeberg T, Angmar-Mansson B,. The influence of acupuncture on salivary flow rates in healthy subjects. J Oral Rehabil. 1997; 24: 204-208. (Pubitemid 127732011)
37. Dawidson I, Angmar-Mansson B, Blom M, Theodorsson E, Lundeberg T,. The influence of sensory stimulation (acupuncture) on the release of neuropeptides in the saliva of healthy subjects. Life Sci. 1998; 63: 659-674. (Pubitemid 28378334)
38. Dawidson I, Angmar-Mansson B, Blom M, Theodorsson E, Lundeberg T,. Sensory stimulation (acupuncture) increases the release of vasoactive intestinal polypeptide in the saliva of xerostomia sufferers. Neuropeptides. 1998; 32: 543-548. (Pubitemid 29010711)
39. Dawidson I, Angmar-Mansson B, Blom M, Theodorsson E, Lundeberg T,. Sensory stimulation (acupuncture) increases the release of calcitonin gene-related peptide in the saliva of xerostomia sufferers. Neuropeptides. 1999; 33: 244-250. (Pubitemid 29398147)
40. Johnstone PA, Peng YP, May BC, Inouye WS, Niemtzow RC,. Acupuncture for pilocarpine-resistant xerostomia following radiotherapy for head and neck malignancies. Int J Radiat Oncol Biol Phys. 2001; 50: 353-357. (Pubitemid 32472263)
41. Johnstone PA, Niemtzow RC, Riffenburgh RH,. Acupuncture for xerostomia: clinical update. Cancer. 2002; 94: 1151-1156. (Pubitemid 34150871)
42. Johnstone PA, Polston GR, Niemtzow RC, Martin PJ,. Integration of acupuncture into the oncology clinic. Palliat Med. 2002; 16: 235-239. (Pubitemid 34537666)
43. Cho JH, Chung WK, Kang W, Choi SM, Cho CK, Son CG,. Manual acupuncture improved quality of life in cancer patients with radiation-induced xerostomia. J Altern Complement Med. 2008; 14: 523-526. (Pubitemid 351873386)
44. Deng L, Gan Y, He S, et al. Chinese Acupuncture and Moxibustion. Beijing, China: Foreign Languages Press; 1997.
45. Deadman P, Al-Khafaji M, Baker K,. A Manual of Acupuncture. East Sussex, England: Journal of Chinese Medicine Publications; 1999.
46. Helms JM,. Acupuncture Energetics: A Clinical Approach for Physicians. Berkeley, CA: Medical Acupuncture Publishers; 1997.
47. Rosenthal DI, Mendoza TR, Chambers MS, et al. Measuring head and neck cancer symptom burden: the development and validation of the M. D Anderson symptom inventory, head and neck module. Head Neck. 2007; 29: 923-931.
48. Littell R, Milliken G, Stroup W, Wolfinger R, Schabenberger O,. SAS for Mixed Models. 2nd ed. Cary, NC: SAS Institute; 2006.
49. Deng G, Hou BL, Holodny AI, Cassileth BR,. Functional magnetic resonance imaging (fMRI) changes and saliva production associated with acupuncture at LI-2 acupuncture point: a randomized controlled study. BMC Complement Altern Med. 2008; 8: 37.